Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953
1 2 3

ACLY

ATP citrate lyase

ACLY; ATP citrate lyase; ATP-citrate synthase; ACL; ATP citrate synthase; ATPCL; CLATP; citrate cleavage enzyme; ATP-citrate (pro-S-)-lyase;

DUSP1

dual specificity phosphatase 1

DUSP1; dual specificity phosphatase 1; PTPN10; dual specificity protein phosphatase 1; CL100; HVH1; MKP 1; MAP kinase phosphatase 1; protein-tyrosine phosphatase CL100; dual specificity protein phosphatase hVH1; serine/threonine specific protein phosphata;

DUSP14

dual specificity phosphatase 14

DUSP14; dual specificity phosphatase 14; dual specificity protein phosphatase 14; MKP 1 like protein tyrosine phosphatase; MKP L; MKP6; MKP-6; MAP kinase phosphatase 6; MKP-1 like protein tyrosine phosphatase; MKP-1-like protein tyrosine phosphatase; mito;

DUSP22

dual specificity phosphatase 22

DUSP22; dual specificity phosphatase 22; dual specificity protein phosphatase 22; JKAP; JSP1; MKPX; VHX; JNK stimulatory phosphatase 1; JSP 1; LMW DSP2; Low molecular weight dual specificity phosphatase 2; MAP kinase phosphatase x; Mitogen activated protein kinase phosphatase x; JSP-1; MKP-x; LMW-DSP2; OTTHUMP00000015938; JNK-stimulating phosphatase 1; JNK-stimulatory phosphatase-1; mitogen-activated protein kinase phosphatase x; homolog of mouse dual specificity phosphatase LMW-DSP2; LMWDSP2;

DUSP3

dual specificity phosphatase 3

DUSP3; dual specificity phosphatase 3; vaccinia virus phosphatase VH1 related , VHR; dual specificity protein phosphatase 3; vaccinia H1-related phosphatase; vaccinia virus phosphatase VH1-related; dual specificity protein phosphatase VHR; serine/threonin;

DUSP6

dual specificity phosphatase 6

DUSP6; dual specificity phosphatase 6; dual specificity protein phosphatase 6; MKP 3; PYST1; MAP kinase phosphatase 3; dual specificity protein phosphatase PYST1; serine/threonine specific protein phosphatase; mitogen-activated protein kinase phosphatase;

DYRK2

dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2

DYRK2; dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2; dual specificity tyrosine-phosphorylation-regulated kinase 2; FLJ21217; FLJ21365;

LCAT

lecithin-cholesterol acyltransferase

LCAT; lecithin-cholesterol acyltransferase; phosphatidylcholine-sterol acyltransferase; LCAT_HUMAN; Lecithin cholesterol acyltransferase; Phosphatidylcholine sterol acyltransferase; Phospholipid cholesterol acyltransferase; Phospholipid-cholesterol acyltransferase;

NBL1

neuroblastoma, suppression of tumorigenicity 1

NBL1; neuroblastoma, suppression of tumorigenicity 1; neuroblastoma suppressor of tumorigenicity 1; D1S1733E; DAN; DAN domain family member 1; DAND 1; DAND1; Differential screening selected gene aberrant in neuroblastoma; MGC8972; NB; NBL 1; Neuroblastoma candidate region suppression of tumorigenicity 1; Neuroblastoma suppression of tumorigenicity 1; NO 3; NO3; Zinc finger protein DAN; N03; OTTMUSP00000010476; Dana; D4H1S1733E;

NCR1

natural cytotoxicity triggering receptor 1

NCR1; natural cytotoxicity triggering receptor 1; LY94, lymphocyte antigen 94 (mouse) homolog (activating NK receptor; NK p46); CD335; NK p46; NKP46; FLJ99094; hNKp46; Ly94; Lymphocyte antigen 94; Lymphocyte antigen 94 homolog (activating NK receptor; Lymphocyte antigen 94 homolog; Natural killer cell p46-related protein; NCT1; NCTR1_HUMAN; NK cell activating receptor; NK cell-activating receptor; NK-p46; lymphocyte antigen 94 homolog (activating NK-receptor; NK-p46);

NCR3

natural cytotoxicity triggering receptor 3

NCR3; natural cytotoxicity triggering receptor 3; LY117, lymphocyte antigen 117; 1C7; CD337; NKp30; Natural killer cell p30 related protein; CD337 antigen; LY117; Lymphocyte antigen 117; NK-p30; OTTHUMP00000029162; OTTHUMP00000029163; OTTHUMP00000029164; OTTHUMP00000029165; activating NK-A1 receptor; activating natural killer receptor p30; natural killer cell p30-related protein; MALS;

ST13

suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)

ST13; suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein); hsc70-interacting protein; FAM10A1; HIP; HSPABP1; P48; progesterone receptor associated p48 protein; SNC6; Hsp70-interacting protein; aging-associated protein 2; putativ;

CALCA

calcitonin-related polypeptide alpha

Alpha CGRP; CALC 1; CALC A; CALC1; CALCA; Calcitonin related polypeptide alpha; CGRP 1; CGRP; CGRP I; CGRP1; CGRPI; CT; Katacalcin; KC; MGC126648;

IDH2

isocitrate dehydrogenase 2 (NADP+), mitochondrial

IDH2; isocitrate dehydrogenase 2 (NADP+), mitochondrial; isocitrate dehydrogenase [NADP], mitochondrial; NADP(+)-specific ICDH; oxalosuccinate decarboxylase; IDH; IDP; IDHM; IDPM; ICD-M; D2HGA2; mNADP-IDH;

DUSP5

dual specificity phosphatase 5

DUSP5; dual specificity phosphatase 5; dual specificity protein phosphatase 5; HVH3; VH1-like phosphatase 3; dual specificity protein phosphatase hVH3; serine/threonine specific protein phosphatase; DUSP;

IDH3B

isocitrate dehydrogenase 3 (NAD+) beta

IDH3B; isocitrate dehydrogenase 3 (NAD+) beta; isocitrate dehydrogenase [NAD] subunit beta, mitochondrial; mitochondrial; FLJ11043; H-IDHB; IDH3B_HUMAN; Isocitrate dehydrogenase [NAD] subunit beta; isocitrate dehydrogenase 3, beta subunit; Isocitric dehydrogenase; Isocitric dehydrogenase subunit beta; MGC903; NAD(+)-specific ICDH; NAD(+)-specific ICDH subunit beta; NAD+-specific isocitrate dehydrogenase b subunit; NAD+-specific isocitrate dehydrogenase beta; OTTHUMP00000030023; OTTHUMP00000030024; RP46; NAD+-specific ICDH; isocitrate dehydrogenase, NAD(+)-specific, mitochondrial, beta subunit; Isocitrate Dehydrogenase (NADP +); Isocitrate Dehydrogenase; IDP; PICD; IDH; IDCD; IDPC; EC 1.1.1.42; Isocitrate dehydrogenase [NADP] cytoplasmic; Cytosolic NADP-isocitrate dehydrogenase; Oxalosuccinate decarboxylase; NADP(+)-specific ICDH; NADP+-specific ICDH; NADP-dependent isocitrate dehydrogenase, cytosolic; NADP-dependent isocitrate dehydrog enase, peroxisomal; isocitrate dehydrogenase 1 (NADP+), soluble; isocitrate dehydrogenase (NADP+); isocitrate dehydrogenase (NADP); oxalsuccinic decarboxylase; isocitrate (NADP) dehydrogenase; isocitrate (nicotinamide adenine dinucleotide phosphate) dehydrogenase; NADP-specific isocitrate dehydrogenase; NADP-linked isocitrate dehydrogenase; NADP-dependent isocitrate dehydrogenase; NADP isocitric dehydrogenase; isocitrate dehydrogenase (NADP-dependent); NADP-dependent isocitric dehydrogenase; triphosphopyridine nucleotide-linked isocitrate dehydrogenase-oxalosuccinate carboxylase; NADP+-linked isocitrate dehydrogenase; IDH (ambiguous); dual-cofactor-specific isocitrate dehydrogenase; IDP1; IDP2; IDP3; isocitrate: NADP+ oxidoreductase (decarboxylating);

LRAT

lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)

LRAT; lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase); lecithin retinol acyltransferase; LCA14; MGC33103;

NFAT5

nuclear factor of activated T-cells 5, tonicity-responsive

NFAT5; nuclear factor of activated T-cells 5, tonicity-responsive; nuclear factor of activated T-cells 5; KIAA0827; NF AT5; NFATL1; NFATZ; OREBP; TONEBP; NFAT-like protein 1; TonE-binding protein; glutamine rich protein H65; T-cell transcription factor NF;

SLC25A13

solute carrier family 25, member 13 (citrin)

SLC25A13; solute carrier family 25, member 13 (citrin); CTLN2; calcium-binding mitochondrial carrier protein Aralar2; ARALAR2; CITRIN; mitochondrial aspartate glutamate carrier 2; AI785475; Calcium binding mitochondrial carrier protein Aralar2; Ctrn; RGD1565889; Solute carrier family 25 (citrin) member 13; Solute carrier family 25 member 13 (citrin); Solute carrier family 25 member 13; OTTHUMP00000024692;

ST14

suppression of tumorigenicity 14 (colon carcinoma)

ST14; suppression of tumorigenicity 14 (colon carcinoma); HAI; MTSP1; SNC19; ARCI11; MT-SP1; PRSS14; TADG15; TMPRSS14; suppressor of tumorigenicity 14 protein; prostamin; serine protease 14; serine protease TADG-15; membrane-type serine protease 1; tumor associated differentially expressed gene 15 protein; tumor-associated differentially-expressed gene 15 protein; suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin);

DUSP28

dual specificity phosphatase 28

DUSP28; dual specificity phosphatase 28; DUSP26; VHP;

DUSP4

dual specificity phosphatase 4

DUSP4; dual specificity phosphatase 4; dual specificity protein phosphatase 4; HVH2; MAP kinase phosphatase 2; MKP 2; TYP; VH1 homologous phosphatase 2; dual specificity protein phosphatase hVH2; serine/threonine specific protein phosphatase; mitogen-acti;

DUSP12

dual specificity phosphatase 12

DUSP12; dual specificity phosphatase 12; dual specificity protein phosphatase 12; DUSP1; serine/threonine specific protein phosphatase; YVH1; YVH1 protein tyrosine phosphatase (S. cerevisiae) ortholog; YVH1 protein-tyrosine phosphatase ortholog; dual spec;

DUSP9

dual specificity phosphatase 9

DUSP9; dual specificity phosphatase 9; dual specificity protein phosphatase 9; map kinase phosphatase 4; MKP 4; MKP4; serine/threonine specific protein phosphatase; mitogen-activated protein kinase phosphatase 4; MKP-4;

DUPD1

dual specificity phosphatase and pro isomerase domain containing 1

DUPD1; dual specificity phosphatase and pro isomerase domain containing 1; dual specificity phosphatase DUPD1; DUSP27; dual specificity phosphatase 27; atypical dual-specific protein phosphatase; FMDSP;

IDH3A

isocitrate dehydrogenase 3 (NAD+) alpha

IDH3A; isocitrate dehydrogenase 3 (NAD+) alpha; isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial; H IDH alpha; isocitrate dehydrogenase (NAD+) alpha chain; isocitrate dehydrogenase [NAD] subunit alpha; mitochondrial; isocitric dehydrogenase; NAD(H) specific isocitrate dehydrogenase alpha subunit; NAD+ specific ICDH; EC 1.1.1.41; HIDH alpha; IDH3A_HUMAN; Isocitrate dehydrogenase (NAD+) alpha chain precursor; Isocitrate dehydrogenase [NAD] subunit alpha mitochondrial; Isocitrate dehydrogenase; Isocitric dehydrogenase subunit alpha; NAD; NAD(+)-specific ICDH subunit alpha; NAD(H) specific isocitrate dehydrogenase alpha subunit precursor; NADsubunit alpha mitochondrial precursor; OTTHUMP00000184906; H-IDH alpha; NAD+-specific ICDH; NAD(H)-specific isocitrate dehydrogenase alpha subunit;

IDH1

isocitrate dehydrogenase 1 (NADP+), soluble

Cytosolic NADP isocitrate dehydrogenase; Cytosolic NADP-isocitrate dehydrogenase; ICDH; IDCD; IDH; IDH1; IDHC_HUMAN; IDP; IDPC; Isocitrate dehydrogenase [NADP] cytoplasmic; Isocitrate dehydrogenase 1 (NADP+) soluble; NADP dependent isocitrate dehydrogenase cytosolic; NADP dependent isocitrate dehydrogenase peroxisomal; NADP(+)-specific ICDH; Oxalosuccinate decarboxylase; PICD; Isocitrate dehydrogenase;

DUSP23

dual specificity phosphatase 23

DUSP23; dual specificity phosphatase 23; dual specificity protein phosphatase 23; DUSP25; FLJ20442; VH1-like member Z; VH1-like phosphatase Z; low molecular mass dual specificity phosphatase 3; low-molecular-mass dual-specificity phosphatase 3; VHZ; MOSP;

DYRK3

dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3

DYRK3; dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3; dual specificity tyrosine-phosphorylation-regulated kinase 3; dual specificity tyrosine (Y) phosphorylation regulated kinase 5; hYAK3 2; protein kinase Dyrk3; RED; REDK; regulatory e;

NCR2

natural cytotoxicity triggering receptor 2

NCR2; natural cytotoxicity triggering receptor 2; LY95, lymphocyte antigen 95 (activating NK receptor; NK p44); CD336; NK p44; CD336 antigen; LY95; Lymphocyte antigen 95 homolog; Natural killer cell p44-related protein; NK cell activating receptor; NKp44; OTTHUMP00000016371; OTTHUMP00000016372; OTTHUMP00000016373; NK cell-activating receptor; NK cell activating receptor (NKp44); lymphocyte antigen 95 (activating NK-receptor; NK-p; NK-p44; dJ149M18.1;

CALCR

calcitonin receptor

CALCR; calcitonin receptor; CT-R; C1A/C1B;

DUSP16

dual specificity phosphatase 16

DUSP16; dual specificity phosphatase 16; dual specificity protein phosphatase 16; KIAA1700; MAPK phosphatase 7; MKP 7; MKP7; MAPK phosphatase-7; MAP kinase phosphatase 7; mitogen-activated protein kinase phosphatase 7; MKP-7; FLJ36298; FLJ40991; MGC129701;

DYRK1B

dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B

DYRK1B; dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B; dual specificity tyrosine-phosphorylation-regulated kinase 1B; minibrain related kinase; MIRK; mirk protein kinase; minibrain-related kinase;

DYRK4

dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4

DYRK4; dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4; dual specificity tyrosine-phosphorylation-regulated kinase 4; Dual specificity tyrosine phosphorylation regulated kinase 4; EC 2.7.12.1; OTTHUMP00000238290; OTTHUMP00000238291; OTTHUMP00000238292;

IDH3G

isocitrate dehydrogenase 3 (NAD+) gamma

IDH3G; isocitrate dehydrogenase 3 (NAD+) gamma; isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial; mitochondrial; H IDHG; H-IDHG; IDH gamma; IDH3G_HUMAN; Isocitrate dehydrogenase [NAD] subunit gamma; Isocitric dehydrogenase; Isocitric dehydrogenase subunit gamma; NAD (H) specific isocitrate dehydrogenase gamma subunit; NAD(+) specific ICDH; NAD(+)-specific ICDH; NAD(+)-specific ICDH subunit gamma; NAD+ specific ICDH; OTTHUMP00000025984; OTTHUMP00000025985; OTTHUMP00000025987; OTTHUMP00000025988; OTTHUMP00000214764; IDH-gamma; NAD+-specific ICDH; NAD (H)-specific isocitrate dehydrogenase gamma subunit; isocitrate dehydrogenase, NAD(+)-specific, mitochondrial, gamma subunit;

SLC13A5

solute carrier family 13 (sodium-dependent citrate transporter), member 5

SLC13A5; solute carrier family 13 (sodium-dependent citrate transporter), member 5; solute carrier family 13 member 5; NACT; Na(+)/citrate cotransporter; sodium-coupled citrate transporter; solute carrier family 13, member 5; sodium-dependent citrate tran;

ST5

suppression of tumorigenicity 5

ST5; suppression of tumorigenicity 5; suppression of tumorigenicity 5 protein; DENN/MADD domain containing 2B; DENND2B; HTS1; p126; DENN domain containing protein 2B; HeLa tumor suppression 1; DENN domain-containing protein 2B; ST 5; ST5_HUMAN;

DUSP19

dual specificity phosphatase 19

DUSP19; dual specificity phosphatase 19; dual specificity protein phosphatase 19; DUSP17; SKRP1; Dual specificity phosphatase TS DSP1; Dual specificity phosphatase TS-DSP1; DUS19_HUMAN; DUSP 17; DUSP 19; LMW DSP3; LMW-DSP3; LMWDSP 3; LMWDSP3; Low molecular weight dual specificity phosphatase 3; MGC138210; Protein phosphatase SKRP1; SAPK pathway regulating phosphatase 1; SAPK pathway-regulating phosphatase 1; SKRP 1; Stress activated protein kinase pathway regulating phosphatase 1; Stress-activated protein kinase pathway-regulating phosphatase 1; TS DSP1; TS-DSP1;

TEV

Xanthomonas axonopodis pv. Citri

X. axonopodis pv. Citri; Xanthomonas axonopodis pv. Citri;

DUSP21

dual specificity phosphatase 21

DUSP21; dual specificity phosphatase 21; dual specificity protein phosphatase 21; LMWDSP21; Low molecular weight dual specificity phosphatase 21; LMW-DSP21; OTTHUMP00000023174; BJ-HCC-26 tumor antigen;

DYRK1A

dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A

DYRK1A; dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A; DYRK, DYRK1, MNBH; dual specificity tyrosine-phosphorylation-regulated kinase 1A; hMNB; MNB/DYRK protein kinase; serine/threonine kinase MNB; mnb protein kinase homolog hp86; protein kinase minibrain homolog; dual specificity YAK1-related kinase; serine/threonine-specific protein kinase; MNB; DYRK; HP86; MNBH; MRD7; DYRK1;

DUSP26

dual specificity phosphatase 26 (putative)

DUSP26; dual specificity phosphatase 26 (putative); dual specificity protein phosphatase 26; DUSP24; MGC1136; DSP-4; MKP-8; MAP kinase phosphatase 8; dual specificity phosphatase SKRP3; dual-specificity phosphatase SKRP3; mitogen-activated protein kinase;

DUSP10

dual specificity phosphatase 10

DUSP10; dual specificity phosphatase 10; dual specificity protein phosphatase 10; MKP 5; MKP5; map kinase phosphatase 5; dual specificity phosphatase MKP-5; serine/threonine specific protein phosphatase; mitogen-activated protein kinase phosphatase 5; MKP;

CALCB

calcitonin-related polypeptide beta

CALCB; calcitonin-related polypeptide beta; CALC2, calcitonin 2; calcitonin gene-related peptide 2; CGRP II; FLJ30166; Beta type CGRP; CALC2; Calcitonin gene related peptide 2; Calcitonin gene related peptide II; Calcitonin related polypeptide, beta; CGRP2; CGRPII; beta-CGRP; calcitonin 2; beta-type CGRP; calcitonin gene-related peptide II; CGRP-II;

CLYBL

citrate lyase beta like

CLYBL; citrate lyase beta like; citrate lyase subunit beta-like protein, mitochondrial; CLB; citrate lyase beta-like; bA134O15.1;

CS

citrate synthase

CS; citrate synthase; citrate synthase, mitochondrial; mitochondrial; CISY_HUMAN; citrate synthetase;

CIT

citron (rho-interacting, serine/threonine kinase 21)

CIT; citron (rho-interacting, serine/threonine kinase 21); citron Rho-interacting kinase; CRIK; KIAA0949; STK21; serine/threonine-protein kinase 21;

CALCRL

calcitonin receptor-like

CALCRL; calcitonin receptor-like; CRLR; CGRPR; calcitonin gene-related peptide type 1 receptor; CGRP type 1 receptor; calcitonin receptor-like receptor;

DUSP2

dual specificity phosphatase 2

DUSP2; dual specificity phosphatase 2; dual specificity protein phosphatase 2; PAC 1; Dual specificity protein phosphatase PAC 1; DUSP 2; PAC1; Serine/threonine specific protein phosphatase; OTTHUMP00000161013; dual-specificity phosphatase 2; dual specificity protein phosphatase PAC-1; PAC-1;

DHDDS

dehydrodolichyl diphosphate synthase

DHDDS; dehydrodolichyl diphosphate synthase; DS; FLJ13102; HDS; Dedol PP synthase; dedol-PP synthase; cis-prenyl transferase; cis-isoprenyltransferase; CIT; CPT; RP59;

DUSP11

dual specificity phosphatase 11 (RNA/RNP complex 1-interacting)

DUSP11; dual specificity phosphatase 11 (RNA/RNP complex 1-interacting); RNA/RNP complex-1-interacting phosphatase; PIR1; Dual specificity protein phosphatase 11; Phosphatase that interacts with RNA/RNP complex 1; RNA/RNP complex interacting phosphatase; RNA/RNP complex1 intereracting phosphatase; Serine/threonine specific protein phosphatase; RNA/RNP complex-interacting phosphatase;

DUSP13

dual specificity phosphatase 13

DUSP13; dual specificity phosphatase 13; dual specificity protein phosphatase 13; BEDP; DUSP13A; DUSP13B; FLJ32450; TMDP; muscle-restricted DSP; branching-enzyme interacting DSP; dual specificity phosphatase SKRP4; testis- and skeletal-muscle-specific DSP;

DUSP18

dual specificity phosphatase 18

DUSP18; dual specificity phosphatase 18; dual specificity protein phosphatase 18; DUSP20; LMWDSP20; Low molecular weight dual specificity phosphatase 20; LMW-DSP20; DSP18; bK963H5.1;

DUSP7

dual specificity phosphatase 7

DUSP7; dual specificity phosphatase 7; dual specificity protein phosphatase 7; MKP X; PYST2; dual-specificity phosphatase-7; dual specificity protein phosphatase PYST2; MKPX; DKFZp586F2224;

DUSP8

dual specificity phosphatase 8

DUSP8; dual specificity phosphatase 8; C11orf81, chromosome 11 open reading frame 81; dual specificity protein phosphatase 8; FLJ42958; H1 phosphatase; vaccinia virus homolog; HB5; HVH 5; serine/threonine specific protein phosphatase; H1 phosphatase, vac;

SPCC74.02c

mRNA cleavage and polyadenylation specificity factor complex associated protein

SPCC74.02c; mRNA cleavage and polyadenylation specificity factor complex associated protein; agglutinin-like; hypothetical protein SPCC74.02c; hypothetical serine-rich protein;

ST18

suppression of tumorigenicity 18 (breast carcinoma) (zinc finger protein)

ST18;suppression of tumorigenicity 18 (breast carcinoma) (zinc finger protein);18695;ENSG00000147488;ZNF387;8q11.23;KIAA0535;suppression of tumorigenicity 18 protein;suppression of tumorigenicity 18 protein;zinc finger protein 387;

ST7L

suppression of tumorigenicity 7 like

ST7L;suppression of tumorigenicity 7 like;18441;ENSG00000007341;ST7R;STLR;FAM4B;1p13.2;FLJ11657, FLJ20284;suppressor of tumorigenicity 7 protein-like;suppressor of tumorigenicity 7 protein-like;ST7-related protein;tumor suppressor ST7 like;

DUSP15

dual specificity phosphatase 15

DUSP15;dual specificity phosphatase 15;16236;ENSG00000149599;VHY;20q11.21;FLJ40111;dual specificity protein phosphatase 15;dual specificity protein phosphatase 15;VH1-related member Y;dual specificity phosphatase-like 15;vaccinia virus VH1-related dual-specific protein phosphatase Y;EC 3.1.3.16 EC 3.1.3.48;

Csl

citrate synthase like

1700007H16Rik;

DUSP27

dual specificity phosphatase 27 (putative)

RGD1560598;

ST7

suppression of tumorigenicity 7

HELG; RAY1; SEN4; TSG7; Fam4a2; 9430001H04Rik;

Cpg1

candidate plasticity gene 1

ST20

suppressor of tumorigenicity 20

VHR

dual specificity phosphatase 3

VHR;

calc1

calc1 Calcitonin-1 [ Salmo salar ]

calc1; Calcitonin-1;

Food Poison: Cellular Toxicity Caused By Nhe Was First Revealed in a Doctoral Thesis

Recently a doctoral research revealed a protein structure of how Bacillus cereus causes toxin. The author is Danh Phung, he found the crystalline structure of NheA. Phung's study is the first to show that the Nhe proteins form structures resembling pores. We know that food poisoning caused byBaci...

The 9th Annual International Conference on Predictive Human Toxicity and ADME/Tox Studies

The 9th Annual International Conference on Predictive Human Toxicity and ADME/Tox Studies 2014 ;will be held in Brussels, Belgium in January 2014. The exact time hasnt published yet. The conference dedicated to advances in predicting human toxicities and screening earlier in the drug discover...

Guide of PCR-assisted Analysis of Protein-DNA Sequence Specificity

PCR-assisted protein-DNA sequence specificity analysis (random binding sites selection) is a new method for screening the specific sequence that binds to the target protein from the random nucleotide sequence library. Multiple binding screening reactions can be used to clone and sequence the exact n...

logo

FOLLOW US

Terms and Conditions        Privacy Policy

Copyright © 2024 Creative BioMart. All Rights Reserved.

Contact Us

  • /

Stay Updated on the Latest Bioscience Trends